FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 11

Author

Admin 422 posts 0 comments

Featured News

New Tax Regime Introduces Revised Perquisite Valuation Thresholds and Slabs from…

Admin Nov 12, 2025
The government has unveiled significant changes to the income taxation rules ahead of the financial year…
Whitepaper

The 5 Steps to Managing U.S. Sales Tax Compliance

Admin Nov 11, 2025
Non-U.S. businesses face challenges in the U.S. market, where sales tax varies across 13,000+ jurisdictions with…
Featured News

Empowering Business Transactions in the Modern Economy

Admin Nov 10, 2025
The business-to-business (B2B) payments landscape is undergoing a rapid transformation, with fintech firms driving…
Featured News

Digital Payments Surge as Consumers Embrace Real-Time Transactions and Cardless…

Admin Nov 7, 2025
The fintech industry is experiencing rapid growth as consumers worldwide adopt real-time payments, cardless…
Featured News

Yiren Digital Unveils AI Strategy at Hong Kong Fintech Week

Admin Nov 6, 2025
Yiren Digital Ltd. (NYSE: YRD), a fintech firm specializing in digital consumer lending, insurance, and technology…
Featured News

Global Banks Accelerate Real-Time Payments Adoption as Cross-Border Volume Surges

Admin Nov 5, 2025
Global financial institutions are rapidly expanding real-time payments infrastructure as cross-border transaction…
Featured News

Digital Payments & Embedded Finance: Redefining the Future of Financial…

Admin Nov 4, 2025
The global financial landscape is undergoing a revolution led by digital payments, embedded finance, and…
Featured News

Future of Finance Operations: AI, Automation, and Strategic Leadership

Admin Nov 3, 2025
The financial world is entering a transformative era as organizations shift from traditional bookkeeping and…
Featured News

LoanLynx.ai Launches, Revolutionizing Real Estate Financing

Admin Oct 31, 2025
New York – A significant shift is underway in real-estate lending: the newly launched platform LoanLynx.ai is set…
Whitepaper

Mosaicx Conversational AI for Financial Services

Admin Oct 30, 2025
Improve the patient experience with conversational AI for healthcare. Mosaicx provides insightful and interactive…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI

    ARTICLE

    Management team’s 2025 market-based Options have vested
    2026-05-13T21:00:00Z
    Share price increase from $6 to $30 triggers full vesting


    Aptose Reports First Quarter 2026 Results 
    2026-05-13T21:00:00Z
    SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib...


    ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:55:00Z
    LIGHTHOUSE POINT, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (OTCQB: ZVSA), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of inflammatory and renal diseases...


    Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:35:00Z
    - Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 - - FDA feedback on use...


    Precision Optics Reports Third Quarter Fiscal Year 2026 Financial Results
    2026-05-13T20:30:00Z
    Conference Call Scheduled for today, May 13, 2026, at 5:00pm ET


    Park Dental Partners Announces First Quarter 2026 Results
    2026-05-13T20:30:00Z
    MINNEAPOLIS, May 13, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK) and affiliated dental practices (“Park Dental Partners,” “we,” “our,” “us,” or the “Company”) today reported its first-quarter...


    Combined General Meeting of June 3, 2026
    2026-05-13T20:30:00Z
    Châtillon, France, May 13, 2026


    EDAP | Focal One to Host Investor Day on June 1, 2026
    2026-05-13T20:30:00Z
    , May 13, 2026 (GLOBE NEWSWIRE) -- EDAP | Focal One to Host Investor Day on June 1, 2026


    Rapid Micro Biosystems Reports First Quarter 2026 Financial Results
    2026-05-13T20:25:58Z
    LEXINGTON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the...


    Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
    2026-05-13T20:07:25Z
    First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026


    Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human...


    SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
    2026-05-13T20:05:00Z
    Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue


    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
    2026-05-13T20:05:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach...


    Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026


    Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress
    2026-05-13T20:05:00Z
    JUPITER, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,...


    Bionano Reports First Quarter 2026 Results and Provides a Business Update
    2026-05-13T20:05:00Z
    Conference call today, May 13, 2026, at 4:30 PM ET


    LogicMark, Inc. Announces Strong First Quarter 2026 Results
    2026-05-13T20:05:00Z
    Revenue Up 24% as Gross Margin Expands to 69.6% and Operating Loss Narrows


    IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
    2026-05-13T20:05:00Z
    NASHVILLE, Tenn., May 13, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its first quarter results:


    Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T20:05:00Z
    100% insulin independence achieved in 10 patients with type 1 diabetes treated with tegoprubart following islet transplantation in UChicago Medicine-led study


    Glass House Brands Reports First Quarter 2026 Financial Results
    2026-05-13T20:05:00Z
    LONG BEACH, Calif. and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF),...


    Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
    2026-05-13T20:05:00Z
    REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial...


    Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
    2026-05-13T20:05:00Z
    CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with...


    Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
    2026-05-13T20:05:00Z
    MIAMI, May 13, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today reported financial...


    Oruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T20:03:27Z
    ORKA-001 EVERLAST-A 16-week data showed 63.5% PASI 100 rate and a favorable tolerability profile, with longer-term data expected in 2H 2026


    Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
    2026-05-13T20:02:00Z
    SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for...


    vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T20:01:00Z
    Phase 3 CATT1 completion of enrollment on track for the third quarter of 2026


    Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
    2026-05-13T20:01:00Z
    Phase 1 proof-of-mechanism study of EQ504 on track to initiate in mid-2026, with data expected approximately six months thereafter


    Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
    2026-05-13T20:01:00Z
    Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million


    aTyr Pharma to Participate in Upcoming Investor Conferences
    2026-05-13T20:01:00Z
    SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary...


    MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
    2026-05-13T20:01:00Z
    ROCKVILLE, Md., May 13, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today reported financial...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.